Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2NET 1Endocrine 1

Conditions

Stomach Neoplasms 1Rectal Neoplasms 1Pancreatic Neoplasms 1Gastrointestinal Neoplasms 1Gastro-enteropancreatic neuroendocrine tumor 1Esophageal Neoplasms 1Colonic Neoplasms 1Carcinoma, Hepatocellular 1Appendiceal Neoplasms 1Anus Neoplasms 1Adenoma, Islet Cell 1

Interventions

Trastuzumab 2Quality of Life 2tipifarnib 1entinostat 1Surveys and Questionnaires 1Ritonavir 1Radiotherapy 1Patient Reported Outcome Measures 1N-Ac-CHAVC-NH2 1Molecular Diagnostic Techniques 1Melphalan 1Magnetic Resonance Spectroscopy 1Interleukin-12 Subunit p35 1Interleukin-12 1Indinavir 1Immunotherapy 1Fluorodeoxyglucose F18 1Fentanyl 1FAPI-46 1Drug Therapy 1Cryotherapy 1Biological Therapy 1Acupuncture Therapy 1Acupressure 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Esophageal Neoplasms × Acupuncture Therapy × Endocrine × Clear all
NCT04505553 2026-01-21

Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer

University of Washington

Phase 2 Completed
78 enrolled 14 charts
EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Anus Neoplasms, Appendiceal Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Adenoma, Islet Cell, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡